Dana Lavian
Foot Surgery · Valencia, CANPI 1720010200
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,009 of the $3,494 with a category attached, or 86.1%. 34 manufacturers reported payments, led by Paragon 28, Inc. at 25.5% of the total. Reporting peaked in 2019 at $1,395 and has fallen 79.5% since, to $286 in 2025.
Across 86 payments — averaging $40.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$891
- Smith+Nephew$539
- Paratek Pharmaceuticals, Inc.$310
- Cardiovascular Systems Inc.$230
- Alafair Biosciences, Inc.$177
- GRT US Holding, Inc.$96
- plus $1K from 28 others
What the payments were for
- Travel & lodging$48514%
- Food & beverage$3,00986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 6 | $891 |
| Smith+Nephew | 9 | $539 |
| Paratek Pharmaceuticals, Inc. | 10 | $310 |
| Cardiovascular Systems Inc. | 5 | $230 |
| Alafair Biosciences, Inc. | 2 | $177 |
| GRT US Holding, Inc. | 4 | $96 |
| Angiodynamics, Inc. | 1 | $78 |
| Forte Bio-pharma LLC | 3 | $76 |
| Bard Peripheral Vascular, Inc. | 2 | $75 |
| Johnson & Johnson | 3 | $74 |
| Organogenesis Inc. | 2 | $74 |
| Globus Medical | 2 | $69 |
| Alfasigma USA, Inc. | 3 | $68 |
| Cook Medical LLC | 2 | $58 |
| ERMI LLC | 2 | $57 |
| Treace Medical Concepts, Inc. | 2 | $55 |
| Stryker(2 entities) | 2 | $52 |
| AbbVie | 3 | $51 |
| Tactile Systems Technology Inc | 3 | $47 |
| Amgen | 2 | $42 |
| Osiris Therapeutics Inc. | 1 | $42 |
| Sandoz | 2 | $41 |
| Orthofix Medical, Inc. | 3 | $39 |
| Zimmer Biomet | 1 | $34 |
| Integra Lifesciences Corporation | 2 | $32 |
| Vertex | 1 | $27 |
| Polynovo North America LLC | 1 | $26 |
| Baudax Bio Inc. | 1 | $23 |
| Biotissue Holdings Inc. | 1 | $22 |
| Medartis Inc. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Linvatec Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,494 in reported general payments places this provider in the 85th percentile of 71 foot surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 14 | $10,275 |
| Ketoconazole | 15 | $462 |
| Terbinafine Hcl | 16 | $234 |
| Cephalexin | 31 | $177 |
| Methylprednisolone | 17 | $117 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Valencia
- Alexander ReyzelmanSan Francisco$137K
- Helen ShnolBeverly Hills$22K
- Benedict ChingFountain Valley$19K
- Zachary KramerEncinitas$14K
- Tara HarringtonElk Grove$12K
- Jack MorganMonterey Park$11K
- Jaehyun KimSunnyvale$7K
- Ingrid EdelmanSan Diego$6K
- Spencer SterlingBellflower$5K
- Beverly SpursConcord$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.